Clinical Chemistry & Immunoassay Validation Suite: 20-Day Precision, Linearity Matrix in Word, Excel

★ CLINICAL CHEMISTRY & IMMUNOASSAY METHOD VALIDATION MASTER SUITE ★
By Your LabCendence™ Regulatory Advisors

The Definitive Institutional Verification Suite for Automated Chemistry & Immunoassay Analyzers, CLSI EP Protocols, AMR Linearity & Total Allowable Error (TEa).

VALUE - $547.00
Formats: Fully Editable Microsoft Word (.docx) + Automated Microsoft Excel (.xlsx) + Print-Ready PDF (.pdf)
Large-Print Standard: Standardized in exact Size 12 font across body paragraphs and data tables for clear physical binder printing.
Clean File Delivery: Zip filename contains 42 characters with zero parentheses, fully compliant with Etsy requirements.

Every clinical chemistry laboratory, core hospital facility, and Physician Office Laboratory (POL) adding a new analyzer—whether Roche cobas, Abbott Alinity, Beckman Coulter DxC/Au, or Siemens Atellica—faces strict federal mandates before patient testing can begin.

Under federal CLIA regulations (42 CFR § 493.1253) and College of American Pathologists (CAP) Chemistry Checklist standards (CHM.13000 through CHM.13600), laboratories cannot simply accept manufacturer claims. You are legally required to independently verify:
1. Accuracy (Method Comparison against a reference analyzer using 40 patient split samples)
2. Precision (Intra-run repeatability and 20-day within-laboratory reproducibility)
3. Reportable Range / AMR Linearity (5-level admixture challenges verifying the measuring interval)
4. Reference Intervals (20-donor transference study to confirm published normal ranges)
5. Carryover & Interferences (Evaluating probe wash efficacy and Hemolysis, Icterus, Lipemia / HIL indices)

Failing to complete a full 20-day precision study, lacking documented AMR linearity admixtures, or failing to empirically verify normal ranges on local patient demographics are among the top citations issued during CLIA, CAP, and COLA surveys.

Laboratory validation consulting firms charge upwards of $7,500 to $15,000 to conduct analyzer validations. The Clinical Chemistry & Immunoassay Method Validation Master Suite provides your Laboratory Director, Chemistry Technical Supervisor, and Medical Laboratory Scientists with an institutional-grade, audit-tested verification framework built from 35+ years of clinical laboratory survey leadership.

━━━━━━━━━━━━━━━━━━━━
WHAT’S INCLUDED IN THIS $597 MASTER VALIDATION SUITE
━━━━━━━━━━━━━━━━━━━━

1. EXPANDED 6-TAB CHEMISTRY & IMMUNOASSAY VALIDATION MATRIX (.XLSX)

An institutional-grade Microsoft Excel command center built to CLSI EP05-A3, EP06-A, EP09c, EP28-A3c, and CAP Chemistry Checklist standards:
• Tab 1: Validation Summary Dashboard: Executive command center tracking intra-assay precision, 20-day reproducibility, 40-patient Deming regression (R ≥ 0.975), AMR linearity recovery, reference interval transference, carryover (k ≤ 0.10%), and Total Error (TE < TEa).
• Tab 2: CLSI EP05-A3 20-Day Precision Calculator: Pre-programmed 20-day precision engine auditing 2 runs/day in duplicate (n=80 determinations per level) across normal and abnormal pools, with automated CV% and within-laboratory imprecision calculations.
• Tab 3: CLSI EP06-A AMR Linearity Matrix: Automated 5-level admixture calculator (neat low to neat high) tracking triplicate determinations, linear regression (R² ≥ 0.990), and percentage recovery across the manufacturer's claimed measuring range.
• Tab 4: CLSI EP09c Method Comparison (40-Patient Split): Data matrix comparing 40 fresh split patient specimens across 5 days against a comparative analyzer, tracking absolute difference, % bias, and clinical decision thresholds.
• Tab 5: Reference Interval Transference & 20-Donor Verification (CLSI EP28-A3c): Transference engine tracking age, gender, fasting status, and observed results to mathematically verify that ≥ 90% (18/20 donors) fall inside manufacturer published normal ranges.
• Tab 6: Sample Carryover & Interference Verification Matrix (CAP CHM.13200): Probe wash audit tool calculating carryover coefficient (k ≤ 0.10%) using HT1-HT3 and LT1-LT3 sequences, plus Hemolysis, Icterus, and Lipemia (HIL) spike evaluations.

2. MASTER METHOD VALIDATION PROTOCOL & SUMMARY DOSSIER (.DOCX)

An exhaustive, 6-section clinical protocol and regulatory summary binder featuring complete reference tables:
• Section 1.0: Master Validation Plan & Regulatory Applicability (CLIA 42 CFR § 493.1253 & CAP CHM.13000+ alignment; scope of moderate/high complexity chemistry and immunoassay analyzers).
• Section 2.0: 20-Day Precision Protocol (CLSI EP05-A3 study designs, 2-run/day cadence, repeatability, and within-laboratory reproducibility formulas).
↳ Includes Table 2.1: CLSI EP05-A3 Precision Specifications & Total Allowable Error Targets (Glucose, Potassium, Creatinine, hs-Troponin, TSH).
• Section 3.0: Analytical Measurement Range (AMR) & Linearity (CLSI EP06-A 5-level volumetric admixture workflows and R² acceptance criteria).
• Section 4.0: Accuracy & Method Comparison Protocol (CLSI EP09c 40-patient split sample designs, Deming regression, and Total Error modeling).
• Section 5.0: Reference Interval Transference & Carryover Evaluation (CLSI EP28-A3c 20-donor transference rules and CAP carryover k-ratio formulas).
↳ Includes Table 5.1: Method Validation Deliverables & Regulatory Sign-Off Checklist.
• Section 6.0: Regulatory Approval & Medical Director Signature Block (Multi-tier sign-off for Lead Technologist, Chemistry Technical Supervisor, and Laboratory Medical Director).

3. CUSTOMER ONBOARDING & SETUP ARCHITECTURE GUIDE (.PDF)
A large-print executive guide detailing 20-day study scheduling, admixture volumetric pipetting, reference donor selection, and inspection day surveyor defense.

━━━━━━━━━━━━━━━━━━━━
REGULATORY STANDARDS SATISFIED
━━━━━━━━━━━━━━━━━━━━
• CLIA: 42 CFR § 493.1253 (Standard: Establishment and Verification of Performance Specifications)
• CAP Accreditation: Chemistry Checklist (CHM.13000 through CHM.13600: Method Validation & Quality Control)
• CLSI Consensus Standards: CLSI EP05-A3 (Evaluation of Precision), CLSI EP06-A (Evaluation of Linearity), CLSI EP09c (Method Comparison), CLSI EP15-A3 (User Verification of Precision), and CLSI EP28-A3c (Reference Intervals)
• Clinical Benchmarks: Westgard Total Allowable Error (TEa) & CLIA 2024 Updated Proficiency Testing Criteria

━━━━━━━━━━━━━━━━━━━━
APPLICABLE TESTING PLATFORMS & ANALYZERS
━━━━━━━━━━━━━━━━━━━━
• Automated Chemistry Analyzers: Roche cobas (c501, c502, c701, pro), Abbott Alinity c / Architect, Beckman Coulter DxC / Au series, Siemens Atellica CH / Dimension Vista
• Automated Immunoassay Analyzers: Roche cobas e-series, Abbott Alinity i, Beckman Coulter DxI series, Siemens Atellica IM / Centaur
• Integrated Core Lab Workcells: Dual chemistry and immunoassay modular configurations

━━━━━━━━━━━━━━━━━━━━
TECHNICAL SPECIFICATIONS & DELIVERY
━━━━━━━━━━━━━━━━━━━━
• Formats: Fully Editable Microsoft Word (.docx), Automated Microsoft Excel (.xlsx), and Print-Ready PDF (.pdf)
• Large-Print Standard: Exact Size 12 font throughout all body paragraphs and data tables for clear physical binder printing
• Clean ZIP Packaging: Instant digital download named Chemistry_Immunoassay_Validation_Suite.zip (42 characters, no upload errors)
• Turnkey & Unlocked: Pre-configured fields for laboratory name, CLIA ID, analyzer serials, and medical director approvals